Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.
Open Access
- 1 June 1986
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 77 (6) , 1864-1872
- https://doi.org/10.1172/jci112513
Abstract
Sitosterolemia and xanthomatosis together are a disease characterized by premature cardiovascular disease, and by elevated plasma concentrations of total sterols and of plant sterols, especially sitosterol which is hyperabsorbed. In order to determine whether this abnormal metabolism also involved other sterols, a patient with sitosterolemia was fed a diet high in shellfish that contain significant quantities of noncholesterol sterols, some of which are less well absorbed than cholesterol in humans. Compared with control subjects (n = 8), the sitosterolemic subject had an increased absorption of 22-dehydrocholesterol (71.5% vs. 43.8 +/- 11.4%, mean +/- SD), C-26 sterol (80.6% vs. 49.3 +/- 11.4%), brassicasterol (51.8% vs. 4.8 +/- 4.2%), and 24-methylene cholesterol (60.5% vs. 16.0 +/- 8.3%). This enhanced absorption was associated with an increased plasma total shellfish sterol level (13.1 mg/dl vs. 1.9 +/- 0.7 mg/dl in normals). In the sitosterolemic subject, as in normals, the shellfish sterols were not preferentially concentrated in any lipoprotein class, and 50-65% of these sterols were in the esterified form in plasma. Bile acids and neutral sterols were quantitated in bile obtained by duodenal aspiration. The bile acid composition did not differ significantly in the sitosterolemic subject compared with the normal controls. The sitosterolemic subject, though, was unable to concentrate normally the neutral shellfish sterols in bile. The normal controls concentrated the shellfish sterols in bile 6.3 +/- 1.7-fold relative to the plasma shellfish sterol concentration whereas the study subject was only able to concentrate them 2.1-fold. We propose that sitosterolemia and xanthomatosis occur from a generalized abnormality in the usual ability of the gut mucosa and other tissues of the body to discriminate among many different sterols. This has important implications for the understanding of the pathophysiology of this disease and for therapeutic recommendations.This publication has 30 references indexed in Scilit:
- The steroids of 2000-year-old human coprolitesJournal of Lipid Research, 1978
- Role of Pancreatic Cholesterol Esterase in the Uptake and Esterification of Cholesterol by Isolated Intestinal CellsExperimental Biology and Medicine, 1977
- β-Sitosterolemia and XanthomatosisNew England Journal of Medicine, 1976
- Effects of neomycin on absorption, synthesis, and/or flux of cholesterol in man.Journal of Clinical Investigation, 1975
- β-Sitosterolemia and XanthomatosisJournal of Clinical Investigation, 1974
- An evaluation of recent gas-liquid chromatographic liquid phases for resolution of acetylated plant sterolsJournal of Chromatography A, 1973
- A Physiological Method for Estimation of Hepatic Secretion of Biliary Lipids in ManGastroenterology, 1972
- Metabolism of β-sitosterol in manJournal of Clinical Investigation, 1970
- Placental transfer of cholesterol-4-14C into rabbit and guinea pig fetusJournal of Lipid Research, 1967
- A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUESJournal of Biological Chemistry, 1957